UNICYCIVE THERAPEUTICS, INC. Costs and Expenses, Related Party
UNICYCIVE THERAPEUTICS, INC. (UNCY) reported Costs and Expenses, Related Party of $2.90 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:CostsAndExpensesRelatedParty · last filed 2026-03-30
- UNICYCIVE THERAPEUTICS, INC. costs and expenses, related party for fiscal 2025 was $2.90M.
| Period end | Costs and Expenses, Related Party | Costs and Expenses, Related Party 1 month | Costs and Expenses, Related Party 12 month |
|---|---|---|---|
| 2025-12-31 | $2.90M 10-K · filed 2026-03-30 | ||
| 2023-04-10 | $2.90M 10-K · filed 2026-03-30 | ||
| 2023-03-31 | $100.00K 10-K · filed 2025-03-31 | $100.00K 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |